TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05546554: Trial of Suvorexant for Sleep in Children With Autism

Sponsor: Stanford University · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 26 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$8,100,800

Rescue Site Savings

+$5,345,200

Unlock Full NCT05546554 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05546554 Rescue Dossier →